Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Data Sinergitama Jaya Tbk. (ELIT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Data Sinergitama Jaya Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Data Sinergitama Jaya Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Data Sinergitama Jaya Tbk. trades at Rp169 (market cap 347.41B, 2.72M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Data Sinergitama Jaya Tbk. is more actively traded (2.72M versus 843K). Which is the better fit depends on your goals.

ELITLABS
Market Cap
347.41B635.95B
Volume
2.72M843K
Lot
27.17K8.43K
Turnover
463.97M137.6M
Average Price
170.77163.22
Value
463.97M137.6M
Indicative Equilibrium Price
169165
Indicative Equilibrium Volume
154246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ELIT
View details
LABS
View details

About Data Sinergitama Jaya Tbk.

PT Data Sinergitama Jaya Tbk (the “Company”) was established based on Notarial Deed No. 38dated June 20, 2011 of Dana Sasmita, S.H., notary in Jakarta. The Company’s immediate and ultimate holding company is PT Gratus Deo Indonesia, a company incorporated in Indonesia.

Read more on ELIT

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS